CEREBROVASCULAR CONSEQUENCES OF SYSTEMIC RIL-2 INFUSION
CEREBROVASCULAR CONSEQUENCES OF SYSTEMIC RIL-2 INFUSION
批准号:
3411373
负责人:
MARY D ELLISON
金额:
$13.4万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1991-06-30
关键词:
中文摘要
初步的临床试验显示系统性的
淋巴因子激活的杀伤细胞(LAK)+rIL-2的应用
诱导某些类型的转移性肿瘤的实质性消退
肿瘤。虽然有时很有效,但这种免疫疗法显示
毒性达到杀死肿瘤细胞所需的剂量水平。毒物
IL-2相关的全身性影响似乎是次要的
微血管通透性增加,到目前为止,IL-2诱导
在脾、肝、肾、肾、脾、肝、肾、脾、肝、肾、肾、脾、肝、脾、肝、肾、肾、脾、肝、肾等器官均有异常改变。
肺和肾血管床。当前的目标是
建议是探索脑微血管的潜力
RIL-2静脉注射后的改变和脑实质改变。
行政部门。这将通过评估IL-2来实现
诱发1)脑血管通透性改变
外源和内源大分子,2)变化
根据评估,软脑膜血管对生理刺激的反应性
通过颅窗检查,3)改变了超微结构特征
脑血管和周围的脑实质,
IL-2相关的局部脑血流量变化。
这些参数将在麻醉大鼠身上进行尖锐的检测,如
在慢性啮齿动物模型中,脑血管
长期服用IL-2的后遗症可以更充分地
已评估。希望这些研究将有助于澄清
临床报告的神经系统症状的潜在机制
IL-2诱导的,以及预测延迟或
持续的不良中枢神经系统影响,尽管公开的
停药后出现症状。
英文摘要
Preliminary clincical trails have shown the systemic
administration of lymphokine-activated killer (LAK) cells + rIL-2
to induce substantial regression of some types of metastatic
tumor. Although somtimes efficacious, this immunotherapy shows
toxicity at dosage levels required for tumor cell killing. Toxic
effects appear to be secondary to an IL-2 associated generalized
increase in microvascular permeability, and, to date, IL-2 induced
abnormalities have been observed in the splenic, hepatic,
pulmonary and renal vascular beds. The objective of the present
proposal is to explore the potential for cerebral microvascular
alteration and brain parenchymal chnage subsequent to rIL-2 i.v.
adminstration. This will be accomplished by evaluating IL-2
induced 1) alterations in cerebrovascular permeability to
macromolecules of exogenous and endogenous origins, 2) changes
in pial vascular reactivity to physiologic stimuli, as assessed
through cranial window studies, 3) altered ultrastructural features
of the cerebral vasculature and surrounding brain parenchyma,
and 4) IL-2 associated changes in regional cerebral blood flow.
These parameters will be examined acutely in anesthesized rats as
well as in a chronic rodent model in which the cerebrovascular
sequelae of longer term IL-2 administration can be more fully
evaluated. It is hoped that these studies will help to clarify the
mechanisms underlying clinically-reported neurological symptoms
induced by IL-2 as well as to predict the likelihood of delayed or
enduring adverse CNS effects despite the disappearance of overt
symptoms upon treatment withdrawal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CEREBROVASCULAR CONSEQUENCES OF SYSTEMIC RIL-2 INFUSION
-
批准号:3411377
-
项目类别:
-
资助金额:$12.79万
-
财政年份:1988
-
负责人:MARY D ELLISON
-
依托单位:
CEREBROVASCULAR CONSEQUENCES OF SYSTEMIC RIL-2 INFUSION
-
批准号:3411376
-
项目类别:
-
资助金额:$12.79万
-
财政年份:1988
-
负责人:MARY D ELLISON
-
依托单位:
海外基金